ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

NCI To Fund Partnerships Between Cancer Centers and Minority Institutions

November 12, 1999

CCIRC Members Now Feel At Home In DCT

March 3, 1978

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

Clinical Trials Approved By NCI CTEP Last Month

April 29, 2011

Budget Process for FY ’81 Starts; Investigators Initiated Definition May Be Heated Issues

August 31, 1979

Letters to the Editor: Us Too! Objects to ODAC Member’s Comments; Brawley Responds

March 28, 2003